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The National Amyotrophic Lateral Sclerosis (ALS) Registry
Vinicius C. Antao, MSc, MD, PhD and D. Kevin Horton, MSPH, DrPH
A myotrophic lateral sclerosis (ALS) is a progressive and often fatal neuromuscular disease. 
Most people die within 2–5 years of being diagnosed with ALS (Mitsumoto, Chad, & Pioro, 
1998). Community concerns about perceived clusters of cases of ALS have challenged 
public health agencies to consider the possible contribution of environmental contaminants 
to the development of this disease. The general categories of possible environmental risk 
factors that have been investigated include heavy metals, trace elements, solvents and other 
volatile organic chemicals, ionizing and non-ionizing radiation, and agricultural chemicals.
Several investigations have been conducted of heavy metal exposure, particularly lead, as a 
risk factor for ALS. Some case-control studies demonstrated a positive association between 
past exposure to lead and risk of ALS (Armon, Kurland, Daube, & O’Brien, 1991; Kamel et 
al., 2002; Roelofs-Iverson, Mulder, Elveback, Kurland, & Molgaard, 1984). Also, the 
epidemiologic literature offers some support for an association between ALS and past 
exposure to organic solvents (Gunnarsson, Lindberg, Söderfeldt, & Axelson, 1991; McGuire 
et al., 1997).
In addition, certain occupations, such as military work, have been listed as a risk factor for 
ALS (Nicholas et al., 1998; Schulte, Burnett, Boeniger, & Johnson, 1996; Sutedja et al., 
2009; Weisskopf et al., 2005). Several other potential risk factors have been evaluated in the 
scientific literature including infectious agents (Fang et al., 2011), nutritional intake 
(Okamoto, Kihira, Kobashi et al., 2009; Wang et al., 2011; Woolsey, 2008), physical 
activity, and trauma (Beghi et al., 2010; Okamoto, Kihira, Kondo et al., 2009; Piazza, Siren, 
& Ehrenreich, 2004; Strickland, Smith, Dolliff, Goldman, & Roelofs, 1996).
The uncertainty about the incidence and prevalence of ALS, as well as the lack of 
knowledge about the role of environmental exposures in the etiology of ALS, has created a 
need for structured data collection. In 2008, President Bush signed the ALS Registry Act 
into law, allowing the Agency for Toxic Substances and Disease Registry (ATSDR) to 
create the National ALS Registry. The purpose of the registry is to quantify the incidence 
and prevalence of ALS in the U.S., describe the demographics of persons with ALS, and 
examine risk factors for the disease.
When the law was enacted, ATSDR was already conducting four pilot projects (during 
2006–2009) to determine the feasibility of creating a National ALS Registry. Results from 
these pilot projects showed that approximately 80% of ALS patients could be found through 
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existing national databases. Combined methodologies would be needed, however, to identify 
a larger portion of individuals with ALS.
In 2009, ATSDR implemented the National ALS Registry using a two-pronged approach to 
better describe the epidemiology of ALS in the U.S. and its potential risk factors. The first 
approach uses existing national administrative databases, including Medicare, Medicaid, 
Veterans Heath Administration, and Veterans Benefit Administration records to identify 
prevalent cases based on an algorithm developed through the pilot projects. The National 
ALS Registry is the first national surveillance system to use existing administrative data as a 
major source of case ascertainment.
The second approach, implemented in the fall of 2010, uses a secure web portal to capture 
cases not included in the national administrative databases. This approach allows patients to 
self-identify and enroll in the ALS registry and take risk factor surveys. Current risk factor 
surveys include sociodemographic characteristics, occupational history (most recent and 
longest held jobs), military history, cigarette smoking, alcohol consumption, physical 
activity, family history of neurodegenerative diseases, and disease progression. In the near 
future, ATSDR expects to include additional surveys on residential history, pesticide 
exposures, occupations and hobbies involving toxic exposures, trauma (e.g., traumatic brain 
injury and electrical shocks), caffeine consumption, reproductive history, and health 
insurance information.
In addition, ATSDR is concurrently implementing surveillance activities that will allow for 
timely population-based case estimates of ALS in smaller defined geographic areas (i.e., at 
the state and metropolitan levels). Currently, Texas, Florida, New Jersey, Philadelphia, 
Chicago, Atlanta, Detroit, Los Angeles, and San Francisco are participating. These local 
surveillance activities will actively identify neurologists who diagnose or provide care for 
persons with ALS and check their medical records to find possible cases of ALS that have 
not been reported to the registry. This process will help ATSDR evaluate the registry’s 
completeness by comparing state and local data to data from the same areas collected in the 
registry. If some areas or groups are not well represented in the registry, ATSDR will find 
ways to reach these populations.
ATSDR is also developing a system to inform persons with ALS about new research studies. 
When researchers send ATSDR information about their studies, ATSDR will verify that the 
study has been approved by the researcher’s institutional review board. Then the agency will 
e-mail information about the study to registrants who have agreed to be contacted about 
such projects. Registrants will have to contact the researcher if they want to be in the study.
Finally, ATSDR is funding a feasibility study for the creation of a national bank of 
biological specimens—blood, saliva, and tissue—known as a bioregistry. These samples 
would come from people in the ALS registry. Linking the specimens to the information 
collected from registry participants will make the registry even more useful.
Many environmental causes have been implicated as the etiology of ALS. This disease, 
however, remains without a definite etiology. Moreover, the true burden of ALS is not 
known in the U.S. The National ALS Registry is responding to these scientific gaps by 
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collecting nationwide data on disease prevalence, assessing risk factors for the development 
of ALS, and exploring ways of facilitating research on ALS. The registry web portal can be 
accessed at www.cdc.gov/als.
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